Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Healthcare Diagnostics & Research Medical Instruments & Supplies

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

(690)
•••

Comment by gebremeskelon Sep 27, 2025 4:20pm

125 Views

Post# 36730207

RE:RE:RE: i-Dialco Inc

Recent comments by Chris Toth indicate a growing interest in home dialysis at Vantive.

https://www.vantive.com/news/insights-perspectives/silent-until-its-not-why-we-cant-wait-another-day-transform-kidney-care?utm_source=CEO+LinkedIn&utm_medium=Social&utm_campaign=Insights+%26+Perspectives%27

"The conversations I've had — including my discussion with Sarah Wells Kocsis from the Milken Institute at the Concordia Annual Summit — reinforced that while the challenges of chronic kidney disease are complex, the path to expand access to home dialysis and improve the care experience is clear."

"The option to do dialysis at home, overnight, while sleeping can provide patients with more freedom to focus on what matters to them. Yet home dialysis remains significantly under-utilized because patients simply don't know enough about this option."

"The time for bold action is now. Our discussions left me more convinced than ever that breaking down the barriers to home dialysis requires collaboration across organizations, sectors, and geographies. We are eager to continue these vital conversations, and partner with stakeholders to drive innovation and adoption of better therapy options for kidney patients."

"We are at a seminal moment and cannot afford to wait. If we don't do something different now, we will have missed an opportunity to save human lives. By keeping the patient and provider experience at the center of everything we do, we can extend lives and expand possibilities for millions of people around the world."

mercedesman wrote:
I'm not counting on a big payday for iDialco either, however Vantive has expressed an interest in the growing field of home dialysis. For that they will need a machine and software to compete with the Outsets and Frenseniuses of this world.

To me, it's more icing on the cake for Vantive ( something they can possibly make into another revenue stream in the future)

More important than however is the EAA icing. The world needs a ESS triage tool ... something to rule out the most deadly form of Sepsis, while time is of the essence. Think of the liability issues now when patients that shouldn't be are sent home.

Not to mention EAA sales worldwide ( supported by a new FDA golden seal of approval on this theranostic approach)

The above three " accessories" have to given some serious consideration by Vantive/CG .

These should not be considered "throw ins" but rather valuable "add-ons"

MM